Evening Primrose Oil for Premenstrual Syndrome
Evening primrose oil is unlikely to relieve premenstrual syndrome: the best-designed studies found it no better than placebo, and major regulators do not back its use. The handful of positive reports come from small or low-quality work, so the evidence is best described as weak and disputed rather than supportive.
Why this grade7-layer evidence engine
The grade reflects a thin, conflicting evidence base. The two most rigorous studies were negative: a double-blind crossover RCT (n=38, six cycles; Khoo 1990, PMID 2201888) found no difference from placebo on any of ten symptom scores and attributed early improvement to a placebo response, and a meta-analysis of placebo-controlled trials (Budeiri 1996, PMID 8721802) concluded the oil is of little value for PMS.
The positive signals are weak. A 2022 systematic review and meta-analysis (Sultana, PMID 36355543) included only one small EPO trial; no EPO-specific effect could be extracted, and its favorable overall conclusion was driven by other herbs such as chasteberry and saffron, not evening primrose oil. A 2019 narrative review (Mahboubi, PMID 31497576) reported symptom scores falling after three months but was non-systematic, low quality, and contradicted the earlier meta-analysis.
Authorities reinforce caution rather than endorsement. The EU's EFSA rejected every health claim for GLA and evening primrose oil, including menstrual discomfort and PMS; the US NCCIH states there is not enough evidence to support use for any condition; the FDA approves no efficacy claims; and the UK NHS warns these unregulated remedies have unproven safety and effectiveness. Clinical guidance favors SSRIs, combined oral contraceptives, and CBT instead, and the oil may interact with blood-thinning medication.
Scoring transparency
All scores computed by a 7-layer evidence engine — fully auditable▸View the full decision path (audit trail)
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.485
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高階證據未達主導 (0 positive vs 1 negative)，由 raw_score 決定
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 1 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status